Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 18;13(2):2927–2942. doi: 10.1080/21655979.2021.2017698

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 7. — miR-665-3p antagomir prevents NAFLD progression via activating AMPKα in vitro. (a) LDH releases in the miR-665-3p antagomir-treated hepatocytes with or without CpC incubated upon PO stimulation. (b) Intracellular TG and TC levels. (c) Cellular ROS levels determined by DCFH-DA probe. (d) MDA levels. (e) The levels of IL-1β, IL-6, MCP-1, TNF-α and IL-10 in the miR-665-3p antagomir-treated hepatocytes with or without CpC incubated upon PO stimulation. All results were expressed as the means ± standard deviations, n = 6 for each group, and *P < 0.05 was considered statistically significant.